{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:22:17Z","timestamp":1761110537911,"version":"3.44.0"},"reference-count":67,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2020,6,8]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) pandemic has come with many challenges for healthcare providers and patients alike. In addition to the direct burden it has placed on societies and health systems, it had a significant impact in the care of patients with chronic diseases, as healthcare resources were deployed to fight the crisis, and major travel and social restrictions were adopted. In the field of rheumatology, this has required notable efforts from departments and clinicians to adapt to the novel <jats:italic>status quo<\/jats:italic> and assure the follow-up of patients with rheumatic and musculoskeletal diseases. In the present viewpoint, we provide a practical approach to tackle this reality. Key measures include setting up preventive team management strategies, optimising communication with patients and reorganising patient care in all its dimensions. We then anticipate the nuances of rheumatology practice as restrictive measures are progressively lifted, while an effective vaccine is still pending. This includes the need to reimpose the same strategy as further waves unfold. Finally, we look ahead and address the lessons we can incorporate into post-COVID-19 rheumatology.<\/jats:p>","DOI":"10.1136\/rmdopen-2020-001314","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T17:09:49Z","timestamp":1593104989000},"page":"e001314","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-9436","authenticated-orcid":false,"given":"Vasco C","family":"Rom\u00e3o","sequence":"first","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"In\u00eas","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Carla","family":"Macieira","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"}]},{"given":"Filipa","family":"Oliveira-Ramos","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Jos\u00e9 Carlos","family":"Romeu","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"}]},{"given":"Carlos Miranda","family":"Rosa","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"}]},{"given":"Maria Jo\u00e3o","family":"Saavedra","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Fernando","family":"Saraiva","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Elsa","family":"Vieira-Sousa","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-3671","authenticated-orcid":false,"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal"},{"name":"Rheumatology Research Unit, Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]}],"member":"239","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"2025090313265788000_6.2.e001314.1","unstructured":"World Health Organization . WHO coronavirus disease (COVID-2019) situation report - 101 [Internet]. Available https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2 (accessed 2020 Apr 30)"},{"key":"2025090313265788000_6.2.e001314.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.02.034"},{"key":"2025090313265788000_6.2.e001314.3","first-page":"1","article-title":"The global impact of COVID-19 and strategies for mitigation and suppression","volume":"2020","author":"Walker","year":"2020","journal-title":"Imp Coll COVID-19 Response Team"},{"key":"2025090313265788000_6.2.e001314.4","article-title":"Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China","volume":"8001","author":"Zhang","year":"2020","journal-title":"Science (80-)"},{"key":"2025090313265788000_6.2.e001314.5","first-page":"2019","article-title":"Effect of the COVID-19 pandemic on cancer treatment and research","volume":"2019","author":"Saini","year":"2020","journal-title":"Lancet Haematol"},{"key":"2025090313265788000_6.2.e001314.6","first-page":"(April):2019\u201321","article-title":"Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China","volume":"2019","author":"Tam","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025090313265788000_6.2.e001314.7","unstructured":"American Cancer Society Cancer Action Network . COVID-19 pandemic impact on cancer patients and survivors survey: findings summary [internet]. Am. Cancer Soc. Cancer Action Netw. 2020;Available https:\/\/www.fightcancer.org\/policy-resources\/covid-19-pandemic-impact-cancer-patients-and-survivors-survey-findings-summary (accessed 2020 Apr 30)"},{"key":"2025090313265788000_6.2.e001314.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217494"},{"key":"2025090313265788000_6.2.e001314.9","first-page":"2019","article-title":"Global rheumatology in the time of COVID-19","volume":"9913","author":"Lewandowski","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2025090313265788000_6.2.e001314.10","unstructured":"American Medical Association . Caring for our caregivers during COVID-19. Am Med Assoc 2020."},{"key":"2025090313265788000_6.2.e001314.11","first-page":"2019","article-title":"Addressing sources of anxiety among health care professionals during the COVID-19 pandemic","volume":"2019","author":"Shanafelt","year":"2020","journal-title":"J Am Med Assoc"},{"key":"2025090313265788000_6.2.e001314.12","unstructured":"European Centre for Disease Prevention and Control . Infection prevention and control and preparedness for COVID-19 in healthcare settings: second update. 31 March 2020. [Internet]. 2020; Available https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Infection-prevention-control-for-the-care-of-patients-with-2019-nCoV-healthcare-settings_update-31-March-2020.pdf (accessed 2020 Apr 28)."},{"key":"2025090313265788000_6.2.e001314.13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2006372","article-title":"Universal masking in hospitals in the COVID-19 era","volume":"382","author":"Klompas","year":"2020","journal-title":"N Engl J Med"},{"key":"2025090313265788000_6.2.e001314.14","first-page":"1","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"6736","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"2025090313265788000_6.2.e001314.15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.15585\/mmwr.mm6915e5","article-title":"Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020","volume":"69","author":"Heinzerling","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025090313265788000_6.2.e001314.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30917-X"},{"key":"2025090313265788000_6.2.e001314.17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus: infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"key":"2025090313265788000_6.2.e001314.18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"He","year":"2020","journal-title":"Nat Med"},{"key":"2025090313265788000_6.2.e001314.19","doi-asserted-by":"crossref","unstructured":"Oran DP , Topol EJ . Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med 2020:M20\u20133012.","DOI":"10.7326\/M20-3012"},{"key":"2025090313265788000_6.2.e001314.20","doi-asserted-by":"crossref","unstructured":"Landew\u00e9 RB , Machado PM , Kroon F , et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis 2020; annrheumdis-2020-217877.","DOI":"10.1136\/annrheumdis-2020-217877"},{"key":"2025090313265788000_6.2.e001314.21","unstructured":"European Centre for Disease Prevention and Control . Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19, 8 April 2020. [Internet]. 2020; Available https:\/\/www.ecdc.europa.eu\/en\/publications-data\/covid-19-guidance-discharge-and-ending-isolation (accessed 29 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.22","unstructured":"World Health Organization . Clinical management of severe acute respiratory infection when COVID-19 is suspected 2020 . (13 Mar 2020). [Internet]. 2020; Available https:\/\/apps.who.int\/iris\/handle\/10665\/331446 (accessed 29 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.23","unstructured":"Centers for Disease Control and Prevention . Criteria for return to work for healthcare personnel with suspected or confirmed COVID-19 (Interim Guidance). [Internet]. 2020; Available https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/return-to-work.html (accessed 30 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2025090313265788000_6.2.e001314.25","doi-asserted-by":"crossref","unstructured":"W\u00f6lfel R , Corman VM , Guggemos W , et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020.","DOI":"10.1101\/2020.03.05.20030502"},{"key":"2025090313265788000_6.2.e001314.26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/jama.2020.2783","article-title":"Positive RT-PCR test results in patients recovered from COVID-19","volume":"323","author":"Lan","year":"2020","journal-title":"JAMA"},{"key":"2025090313265788000_6.2.e001314.27","doi-asserted-by":"crossref","unstructured":"Haberman R , Axelrad J , Chen A , et al. COVID-19 in immune-mediated inflammatory diseases: case series from New York. N Engl J Med 2020;NEJMc2009567.","DOI":"10.1056\/NEJMc2009567"},{"key":"2025090313265788000_6.2.e001314.28","unstructured":"Gianfrancesco M , Hyrich KL , Al-Adely S , et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis 2020;1\u20138."},{"key":"2025090313265788000_6.2.e001314.29","doi-asserted-by":"crossref","unstructured":"D\u2019Silva KM , Serling-Boyd N , Wallwork R , et al. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u201chot spot\u201d. Ann Rheum Dis 2020;1\u20137.","DOI":"10.1136\/annrheumdis-2020-217888"},{"key":"2025090313265788000_6.2.e001314.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"2025090313265788000_6.2.e001314.31","first-page":"S67","article-title":"Infections and treatment of patients with rheumatic diseases","volume":"26","author":"Atzeni","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313265788000_6.2.e001314.32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semarthrit.2011.01.008","article-title":"Emerging viral infections in rheumatic diseases","volume":"41","author":"Khasnis","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313265788000_6.2.e001314.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1997-5","article-title":"Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study","volume":"21","author":"Hsu","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090313265788000_6.2.e001314.34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025090313265788000_6.2.e001314.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"2025090313265788000_6.2.e001314.36","doi-asserted-by":"crossref","unstructured":"Mehra MR , Desai SS , Kuy S , et al. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med 2020;NEJMoa2007621.","DOI":"10.1056\/NEJMoa2007621"},{"key":"2025090313265788000_6.2.e001314.37","first-page":"693","article-title":"Cardiovascular comorbidity in rheumatic diseases","volume":"323","author":"Nurmohamed","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025090313265788000_6.2.e001314.38","unstructured":"Tocilizumab improves significantly clinical outcomes of patients with moderate or severe COVID-19 pneumonia. [Internet]. 2020. Available https:\/\/www.aphp.fr\/contenu\/tocilizumab-improves-significantly-clinical-outcomes-patients-moderate-or-severe-covid-19 (accessed 28 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.39","doi-asserted-by":"crossref","unstructured":"Xu X , Han M , Li T , et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci 2020;202005615.","DOI":"10.1073\/pnas.2005615117"},{"key":"2025090313265788000_6.2.e001314.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"2025090313265788000_6.2.e001314.41","doi-asserted-by":"crossref","unstructured":"Cantini F , Niccoli L , Matarrese D , et al. Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact. J Infect 2020;2020:(16 April 2020).","DOI":"10.1016\/j.jinf.2020.04.017"},{"key":"2025090313265788000_6.2.e001314.42","doi-asserted-by":"crossref","unstructured":"Xie Y , Cao S , Dong H , et al. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect 2020. (accessed 26 Mar 2020)","DOI":"10.1016\/j.jinf.2020.03.044"},{"key":"2025090313265788000_6.2.e001314.43","unstructured":"AV H , Roman YM , Pasupuleti V , et al. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med 2020."},{"key":"2025090313265788000_6.2.e001314.44","doi-asserted-by":"crossref","unstructured":"Deftereos S , Giannopoulos G , Vrachatis DA , et al. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Eur Hear J Cardiovasc Pharmacother 2020;12462.","DOI":"10.1093\/ehjcvp\/pvaa033"},{"key":"2025090313265788000_6.2.e001314.45","article-title":"Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019","volume":"2","author":"Villar","year":"2020","journal-title":"Crit Care Explor"},{"key":"2025090313265788000_6.2.e001314.46","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025090313265788000_6.2.e001314.47","unstructured":"World Health Organization . The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19: scientific brief . [Internet]. 2020; https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331796\/WHO-2019-nCoV-Sci_Brief-NS (accessed 27 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.48","doi-asserted-by":"crossref","unstructured":"Mikuls TR , Johnson SR , Fraenkel L , et al. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 1. Arthritis Rheumatol 2020;1\u201311.","DOI":"10.1002\/art.41301"},{"key":"2025090313265788000_6.2.e001314.49","doi-asserted-by":"crossref","unstructured":"Matucci-Cerinic M , Bruni C , Allanore Y , et al. Systemic sclerosis and the COVID-19 pandemic: world scleroderma foundation preliminary advice for patient management. Ann Rheum Dis 2020;1\u20133.","DOI":"10.1136\/annrheumdis-2020-217407"},{"key":"2025090313265788000_6.2.e001314.50","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209201"},{"key":"2025090313265788000_6.2.e001314.51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41584-019-0201-2","article-title":"Tapering bDMARDs in axial SpA: what is the current evidence?","volume":"15","author":"Ziade","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2025090313265788000_6.2.e001314.52","doi-asserted-by":"crossref","unstructured":"Pinto AJ , Dunstan DW , Owen N , et al. Combating physical inactivity during the COVID-19 pandemic. Nat Rev Rheumatol 2020;19\u201320.","DOI":"10.1038\/s41584-020-0427-z"},{"key":"2025090313265788000_6.2.e001314.53","first-page":"45","article-title":"Reuma.pt - the rheumatic diseases Portuguese register","volume":"36","author":"Canhao","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"2025090313265788000_6.2.e001314.54","doi-asserted-by":"crossref","unstructured":"Robinson PC , Yazdany J . The COVID-19 global rheumatology alliance: collecting data in a pandemic. Nat Rev Rheumatol 2020.","DOI":"10.1038\/s41584-020-0418-0"},{"key":"2025090313265788000_6.2.e001314.55","unstructured":"CDC . Centers for disease control and prevention. Use of cloth face coverings to help slow the spread of COVID-19 [Internet]. 2020. Available https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/diy-cloth-face-coverings.html (accessed 29 Apr 2020)"},{"key":"2025090313265788000_6.2.e001314.56","doi-asserted-by":"crossref","unstructured":"Kellam P , Barclay W . The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J Gen Virol 2020.","DOI":"10.20944\/preprints202004.0377.v1"},{"key":"2025090313265788000_6.2.e001314.57","first-page":"M20","article-title":"Serodiagnostics for severe acute respiratory syndrome: related coronavirus-2","volume":"0","author":"Cheng","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025090313265788000_6.2.e001314.58","unstructured":"Long Q , Liu B-Z , Deng H-J , et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020."},{"key":"2025090313265788000_6.2.e001314.59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/diagnostics10050319","article-title":"Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis","volume":"10","author":"Kontou","year":"2020","journal-title":"Diagnostics"},{"key":"2025090313265788000_6.2.e001314.60","doi-asserted-by":"crossref","unstructured":"Wu F , Wang A , Liu M , et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv 2020.","DOI":"10.1101\/2020.03.30.20047365"},{"key":"2025090313265788000_6.2.e001314.61","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30196-1"},{"key":"2025090313265788000_6.2.e001314.62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/d41586-020-01027-y","article-title":"Safely conducting essential research in the face of COVID-19","volume":"580","author":"Gewin","year":"2020","journal-title":"Nature"},{"key":"2025090313265788000_6.2.e001314.63","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.2020.5227","article-title":"Medical student education in the time of COVID-19","volume":"323","author":"Rose","year":"2020","journal-title":"JAMA"},{"key":"2025090313265788000_6.2.e001314.64","unstructured":"Fitzpatick M , Roycroft M , Hynes G Towards a \u2018new normal\u2019 for physician training following COVID-19 [Internet]. R. Coll. Physicians. 2020. Available https:\/\/www.rcplondon.ac.uk\/news\/towards-new-normal-physician-training-following-covid-19 (accessed 29 May 2020)"},{"key":"2025090313265788000_6.2.e001314.65","unstructured":"EMA (European Medicines Agency) . Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic - version 3 . 2020. V3 (accessed 28 Apr 2020)."},{"key":"2025090313265788000_6.2.e001314.66","unstructured":"Perniola S , Alivernini S , Varriano V , et al. Telemedicine will not keep us apart in COVID-19 pandemic. Ann Rheum Dis 2020;0:annrheumdis-2020-218022."},{"key":"2025090313265788000_6.2.e001314.67","doi-asserted-by":"publisher","DOI":"10.5334\/ijic.1852"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2020-001314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:27:16Z","timestamp":1756931236000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2020-001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,25]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/rmdopen-2020-001314"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2020-001314","relation":{},"ISSN":["2056-5933"],"issn-type":[{"type":"electronic","value":"2056-5933"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}